Genmab A/S is a Danish biotechnology company, founded in February 1999 by Florian Schönharting, at the time managing director of BankInvest Biomedical venture fund. From Wikipedia
The deal enhances Genmab's portfolio with advanced antibody-drug conjugates, marking a significant move in the pharmaceutical industry's focus on targeted cancer therapies.
